M. Dal Pos

Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).

D. Bruttomesso, S. Costa, F. Pellicanò, 2011, Diabetes & metabolism.

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine

D. Bruttomesso, A. Maran, D. Bruttomesso, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Interactive diary for diabetes: A useful and easy-to-use new telemedicine system to support the decision-making process in type 1 diabetes.

Giacomo Vespasiani, Fabio Pellegrini, D. Bruttomesso, 2009, Diabetes technology & therapeutics.

Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.

A. Gallo, F. Piarulli, A. Pianta, 2015, Clinical therapeutics.

Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients

A. Avogaro, G. Fadini, V. Frison, 2013, Acta Diabetologica.

Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge.

R Gagnayre, D Bruttomesso, S Costa, 2006, Diabetes & metabolism.